Exparel is a multivesicular liposomal combined therapy product including bupivacaine with a delivery technology – DepoFoam.
Exparel with DepoFoam delivers bupivacaine for an extended period of time, providing analgesia for up to 72 hours.
University of California surgery associate professor Sonia Ramamoorthy said Exparel, a single dose administration, non-opioid therapy, has the potential to reduce or delay the use of opioids following inpatient and outpatient surgical procedures.